AI
Wednesday, January 05, 2011 7:59:22 AM
Teva’s CFO said they estimate approval of generic Lovenox during 1Q11.
Which, IF TRUE, means the Wedbush writeup is unduly bullish.
Of course, this is at least the third incarnation of "when" TEVA expects approval.
ij
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
